resveratrol has been researched along with silybin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Althagafy, HS; Croatt, MP; Graf, TN; Gufford, BT; Oberlies, NH; Paine, MF; Polyak, SJ; Sy-Cordero, AA; Wagoner, J | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Bijak, M; Krotkiewski, H; Nowak, P; Pawlaczyk, I; Ponczek, M; Saluk, J; Wachowicz, B; Ziewiecki, R | 1 |
| Kalra, S; Khatik, GL; Kumar, GN; Kumar, R; Narang, R; Nayak, SK; Singh, SK; Sudhakar, K | 1 |
| McCarty, MF | 1 |
| Bubley, G; Klempner, SJ | 1 |
| Hadjipavlou, M; Khan, S; Philippou, Y; Rane, A | 1 |
| Argikar, AA; Brantley, SJ; Lin, YS; Nagar, S; Paine, MF | 1 |
| Coppo, L; Gonzalez-Menendez, P; Hevia, D; Holmgren, A; Lu, J; Mayo, JC; Rodriguez-Garcia, A; Sainz, RM | 1 |
| Arici, MA; Atabey, N; Durmus, N; Ergur, BU; Kalkan, S; Sahin, A; Tuncok, Y; Yakut Aksu, I; Yilmaz, Y | 1 |
| Ezhilarasan, D; Lakshmi, T | 1 |
| Adem, Ş; Jabeen, F; Rasul, A; Sarfraz, I; Sultana, T | 1 |
5 review(s) available for resveratrol and silybin
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Recent advancements in mechanistic studies and structure activity relationship of F
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Proton-Translocating ATPases; Structure-Activity Relationship | 2019 |
Complementary and alternative medicines in prostate cancer: from bench to bedside?
Topics: Antioxidants; Beverages; Complementary Therapies; Curcuma; Humans; Lythraceae; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Tea; Vitamin E; Vitamins | 2012 |
Complementary and alternative medicine (CAM) in prostate and bladder cancer.
Topics: Acupuncture; Antineoplastic Agents; Antioxidants; Camellia sinensis; Complementary Therapies; Drugs, Chinese Herbal; Female; Humans; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Urinary Bladder Neoplasms; Vitamin E; Vitamins | 2013 |
A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases.
Topics: Antioxidants; Humans; Liver; Liver Neoplasms; NF-kappa B; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Resveratrol; Silybin; Silymarin | 2022 |
8 other study(ies) available for resveratrol and silybin
| Article | Year |
|---|---|
Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle.
Topics: Antiviral Agents; Aryl Hydrocarbon Hydroxylases; Cell Line; Cell Survival; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Drug Interactions; Glucuronosyltransferase; Hepacivirus; Hepatitis C; Humans; Methylation; Microsomes; Silybum marianum; Silymarin | 2013 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Thrombin inhibitory activity of some polyphenolic compounds.
Topics: | 2014 |
Potential utility of natural polyphenols for reversing fat-induced insulin resistance.
Topics: Adipocytes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Flavonoids; Humans; I-kappa B Kinase; Insulin Resistance; Models, Biological; Phenols; Polyphenols; Probenecid; Protein Serine-Threonine Kinases; Resveratrol; Silybin; Silymarin; Stilbenes | 2005 |
Herb-drug interactions: challenges and opportunities for improved predictions.
Topics: Animals; Computer Simulation; Drug Design; Drug Evaluation, Preclinical; Government Regulation; Herb-Drug Interactions; Humans; Legislation, Drug; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Plant Preparations; Resveratrol; Silybin; Silybum marianum; Silymarin; Stilbenes | 2014 |
Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells.
Topics: Apoptosis; Carrier Proteins; Cell Line, Tumor; Cell Survival; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Male; Melatonin; Prostatic Neoplasms; Reactive Oxygen Species; Resveratrol; Silybin; Silymarin; Stilbenes; Thioredoxins | 2017 |
A Comparison of the Effectiveness of Silibinin and Resveratrol in Preventing Alpha-Amanitin-Induced Hepatotoxicity.
Topics: Alanine Transaminase; Alpha-Amanitin; Antioxidants; Aspartate Aminotransferases; Caspase 3; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Humans; Liver; Mushroom Poisoning; Nucleic Acid Synthesis Inhibitors; Protective Agents; Resveratrol; Silybin; Silymarin; Stilbenes | 2018 |
Identification of Natural Compounds as Inhibitors of Pyruvate Kinase M2 for Cancer Treatment.
Topics: Cell Line, Tumor; Curcumin; Ellagic Acid; Glycolysis; Humans; Leukemia, Myeloid, Acute; Pyruvate Kinase; Resveratrol; Silybin | 2022 |